Search

Your search keyword '"Bilora, F"' showing total 187 results

Search Constraints

Start Over You searched for: Author "Bilora, F" Remove constraint Author: "Bilora, F"
187 results on '"Bilora, F"'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

6. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

7. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

8. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

9. Timing and characteristics of venous thromboembolism after noncancer surgery

10. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

11. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

12. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

13. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

14. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

15. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

16. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

17. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

18. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

19. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

20. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

21. DVT Management and Outcome Trends, 2001 to 2014

22. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

23. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

24. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

25. Autonomic dysfunction and primary antiphospholipid syndrome: a frequent and frightening correlation?

26. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

27. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

28. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

29. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

30. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

31. Timing and characteristics of venous thromboembolism after noncancer surgery

32. Predictors of active cancer thromboembolic outcomes

33. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

34. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry

35. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

37. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

39. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry

41. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

42. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

43. Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database

44. Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry

45. Venous thromboembolism in young adults: Findings from the RIETE registry

46. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

47. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

48. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

49. Mortality after pulmonary embolism in patients with diabetes. Findings from the RIETE registry

50. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis

Catalog

Books, media, physical & digital resources